OBJECTIVE: One of the problems in the application of physiologically based pharmacokinetic (PB-PK) models is that authors often use different input parameters, with unknown influence on the results. Differences in the simulation results obtained with various sets of parameters are examined herein. METHOD: Chemicals considered were perchloroethylene, toluene, and styrene. Simulations of alveolar concentrations, blood concentrations, and urinary metabolite excretions were performed for the three solvents. The input parameters discussed herein are physiological values, metabolic constants, and partition coefficients. The influence of metabolic constants and partition coefficients is studied by comparison of models against one another. RESULTS:...
Abstract Background The application of physiologically based pharmacokinetic models (PBPK) to human ...
The objectives of the simulation study were to evaluate the impact of BQL data on pharmacokinetic (P...
Physiologically based pharmacokinetic (PBPK) models are used in mode-of-action based risk and safety...
OBJECTIVE: One of the problems in the application of physiologically based pharmacokinetic (PB-PK) m...
Assessment of human exposure to environmental chemicals is inherently subject to uncertainty and var...
Allometric scaling is widely used to predict human pharmacokinetic parameters from preclinical speci...
Pharmacokinetics is the study of the time course for the absorption, distribution, metabolism, and e...
A physiologically based pharmacokinetic (PBPK) model for isopropanol (IPA) and its major metabolite,...
Physiologically-based pharmacokinetic and cellular kinetic models are used extensively to predict co...
Pharmacokinetics is the study of the fate of xenobiotics in a living organism. Physiologically based...
International audiencePhysiologically based pharmacokinetic (PBPK) models are used in mode-of-action...
International audiencePhysiologically based pharmacokinetic (PBPK) models have proven to be successf...
International audiencePhysiologically based pharmacokinetic (PBPK) models are often optimized by adj...
International audiencePharmacokinetics study the fate of xenobiotics in a living organism. Physiolog...
It has become common practice to rely on fitted estimates of apparent in vivo metabolic constants (e...
Abstract Background The application of physiologically based pharmacokinetic models (PBPK) to human ...
The objectives of the simulation study were to evaluate the impact of BQL data on pharmacokinetic (P...
Physiologically based pharmacokinetic (PBPK) models are used in mode-of-action based risk and safety...
OBJECTIVE: One of the problems in the application of physiologically based pharmacokinetic (PB-PK) m...
Assessment of human exposure to environmental chemicals is inherently subject to uncertainty and var...
Allometric scaling is widely used to predict human pharmacokinetic parameters from preclinical speci...
Pharmacokinetics is the study of the time course for the absorption, distribution, metabolism, and e...
A physiologically based pharmacokinetic (PBPK) model for isopropanol (IPA) and its major metabolite,...
Physiologically-based pharmacokinetic and cellular kinetic models are used extensively to predict co...
Pharmacokinetics is the study of the fate of xenobiotics in a living organism. Physiologically based...
International audiencePhysiologically based pharmacokinetic (PBPK) models are used in mode-of-action...
International audiencePhysiologically based pharmacokinetic (PBPK) models have proven to be successf...
International audiencePhysiologically based pharmacokinetic (PBPK) models are often optimized by adj...
International audiencePharmacokinetics study the fate of xenobiotics in a living organism. Physiolog...
It has become common practice to rely on fitted estimates of apparent in vivo metabolic constants (e...
Abstract Background The application of physiologically based pharmacokinetic models (PBPK) to human ...
The objectives of the simulation study were to evaluate the impact of BQL data on pharmacokinetic (P...
Physiologically based pharmacokinetic (PBPK) models are used in mode-of-action based risk and safety...